WhatsApp +852 9339 8574
Prostamax is a synthetic short-peptide raw material of research grade—often designated in academic literature by the abbreviation KEDP—that functions as an organ-targeted bioregulatory peptide. Typically prepared as a white lyophilized powder, it exhibits high purity and robust physicochemical stability, making it widely applicable in fundamental research at the cellular level. Thanks to its unique amino acid sequence, Prostamax can modulate gene expression levels in specific glandular tissue cells, making it a peptide of significant interest in studies concerning tissue homeostasis. Physically, the lyophilized powder is uniform and fine, resisting clumping; when stored in sealed, low-temperature, and light-protected conditions, it retains its activity over the long term, minimizing component loss due to molecular degradation and meeting the needs of laboratories requiring long-term storage and batch sampling. Subjected to rigorous purification processes, the product achieves a purity of 99% or higher. A Certificate of Analysis (COA) is provided, clearly listing testing parameters to facilitate quality verification by researchers and ensure the stability and reproducibility of experimental data.
At the molecular level, Prostamax acts as an active short peptide targeting glandular tissues; it interacts with target cells to regulate intracellular gene transcription, optimize metabolic rhythms, and maintain the normal growth state of glandular cells. Glandular cells often experience functional fluctuations due to culture duration or external environmental stressors; Prostamax participates in cell signaling pathways, balancing the dynamic relationship between cell proliferation and metabolism, thereby mitigating tissue homeostasis imbalances caused by abnormal cellular activity. Extensive *in vitro* data indicate that this peptide acts on glandular stromal cells to optimize extracellular matrix synthesis, preserve internal structural integrity, and stabilize the microscopic architecture of the glandular tissue. In tissue culture systems, the addition of appropriate amounts of Prostamax improves the cellular microenvironment, mitigates the negative impact of external stressors on cell viability, and extends the survival period of cultured cells, thereby providing stable conditions for long-term tissue culture research.
The research value of Prostamax lies primarily in the field of fundamental research concerning glandular tissue homeostasis. As vital components of biological tissue systems, glandular cells rely on specific states of growth, renewal, and metabolism to maintain overall tissue function. In standard *in vitro* cultures, glandular cells often experience reduced viability and metabolic dysregulation during continuous passaging, which can compromise experimental outcomes. By targeting and regulating gene expression in glandular cells, Prostamax helps preserve intrinsic metabolic characteristics and mitigates functional decline during prolonged culture, enabling researchers to obtain more stable and reliable samples for observation.
Regarding the tissue microenvironment, Prostamax modulates local cytokine secretion and balances the levels of various bioactive substances, thereby optimizing the microenvironment surrounding glandular tissue. Since glandular health depends heavily on a stable local microenvironment—where imbalances in bioactive substances can directly alter cellular growth—Prostamax gently regulates secretory activity. It promotes orderly metabolic patterns and minimizes disruptions to tissue architecture caused by the accumulation of aberrant bioactive substances. These properties make Prostamax a valuable reagent for studying glandular microenvironment regulation, facilitating research into the mechanisms of interaction between different cell types within the tissue.
Prostamax is currently designated exclusively for laboratory research applications. Common uses include *in vitro* glandular cell culture, investigations into tissue homeostasis, studies on the interplay between short peptides and cellular genes, and screening assays for bioactive substances. Many basic biology laboratories use Prostamax alongside other reagents in controlled experiments to compare the differential effects of various bioactive substances on glandular cells, thereby elucidating the signaling pathways through which short peptides act. In comparative studies of peptide activity, researchers often include Prostamax in short-peptide screening libraries to evaluate the regulatory capabilities of peptides with different sequences. This process helps uncover the structure-activity relationships of short-peptide molecules, generating foundational data for the future development of novel bioactive peptides. Prostamax is produced using solid-phase peptide synthesis technology. The process involves multiple rounds of purification, filtration, and lyophilization to remove residual impurities, short peptide fragments, and solvents, thereby ensuring high product purity. Each batch of raw material undergoes quality verification via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS); the results are documented in a Certificate of Analysis (COA). Strict control over batch-to-batch variation minimizes experimental interference caused by inconsistencies between lots. The product is supplied as a lyophilized powder in sealed vials; this packaging effectively excludes moisture and oxygen, maximizing the preservation of the peptide chain structure and preventing loss of biological activity. For transport, the lyophilized powder can be shipped with cold-chain packaging to further ensure stability during long-distance transit.
Regarding storage and usage, Prostamax lyophilized powder should be stored in a sealed container at -20°C, protected from light. Repeated freeze-thaw cycles and temperature fluctuations must be avoided, as they can disrupt the peptide chain structure and reduce biological activity. Sampling should be performed quickly in a dry, low-temperature environment to minimize prolonged exposure to air. When reconstituting the powder, an appropriate buffer solvent should be used, and the concentration adjusted according to the experimental protocol; the resulting solution should be prepared fresh for immediate use rather than stored for extended periods. Personnel must adhere to standard laboratory safety protocols, wear appropriate protective gear, and strictly follow the experimental procedure regarding dosage, without arbitrarily altering the concentration.
Compared to other peptide materials in the same research field, Prostamax is distinguished by its specific targeting of glandular tissues. While many broad-spectrum bioactive peptides act on various cell types with wide-ranging regulatory effects, the specific amino acid sequence of Prostamax confers a preference for glandular cells. In targeted studies involving glandular tissue, this specificity minimizes off-target effects on other cell types, allowing for greater control over experimental variables. While other tissue-repair peptides tend to offer broad-spectrum cellular repair suitable for various epithelial and connective tissue studies, Prostamax focuses specifically on the regulation of glandular cell metabolism and gene expression, making it ideal for targeted research into glandular tissue homeostasis.
As peptide research advances, an increasing number of laboratories are recognizing the potential scientific value of tissue-specific short peptides. Characterized by low molecular weight, ease of cellular uptake, and relatively well-defined targets, these peptides have become popular materials in modern basic biological research. As a gland-targeting short peptide, Prostamax is supported by a growing body of *in vitro* data that elucidates its mechanisms of action and opens new avenues for glandular research. High-purity, lyophilized Prostamax powder is an ideal choice for research teams engaged in basic biology, peptide activity screening, and tissue/cell culture. Suppliers offer various packaging specifications and support small-batch trial orders, allowing teams to conduct preliminary experiments and verify material suitability before committing to bulk purchases for long-term projects. Comprehensive product documentation is available, and suppliers provide timely responses to inquiries regarding specifications, storage, and testing to facilitate the progress of research projects.
This product is intended solely for *in vitro* laboratory research and is not suitable for other applications. All experimental procedures must be conducted in a professional laboratory setting by qualified personnel. Purchasers may select specifications and purity standards based on their specific experimental designs; inquiries regarding sample pricing and Certificates of Analysis (COA) can be made directly online.
TDS
United States
Australia
